Eudaimonia Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,270
| Closed | -$422K | – | 261 |
|
|
2023
Q3 | $422K | Buy |
7,270
+4
| +0.1% | +$232 | 0.1% | 192 |
|
|
2023
Q2 | $465K | Sell |
7,266
-2,424
| -25% | -$155K | 0.1% | 196 |
|
|
2023
Q1 | $672K | Buy |
9,690
+200
| +2% | +$13.9K | 0.16% | 138 |
|
|
2022
Q4 | $683K | Sell |
9,490
-323
| -3% | -$23.2K | 0.17% | 139 |
|
|
2022
Q3 | $698K | Sell |
9,813
-4,396
| -31% | -$313K | 0.18% | 128 |
|
|
2022
Q2 | $1.09M | Sell |
14,209
-2,047
| -13% | -$158K | 0.2% | 128 |
|
|
2022
Q1 | $1.19M | Buy |
+16,256
| New | +$1.19M | 0.2% | 130 |
|
|
2021
Q3 | $972K | Sell |
16,435
-1,949
| -11% | -$115K | 0.18% | 146 |
|
|
2021
Q2 | $1.23M | Buy |
18,384
+1,802
| +11% | +$120K | 0.23% | 116 |
|
|
2021
Q1 | $1.05M | Buy |
16,582
+479
| +3% | +$30.2K | 0.22% | 114 |
|
|
2020
Q4 | $998K | Buy |
16,103
+99
| +0.6% | +$6.14K | 0.22% | 109 |
|
|
2020
Q3 | $965K | Buy |
16,004
+1,959
| +14% | +$118K | 0.25% | 100 |
|
|
2020
Q2 | $825K | Sell |
14,045
-331
| -2% | -$19.4K | 0.31% | 84 |
|
|
2020
Q1 | $801K | Buy |
14,376
+205
| +1% | +$11.4K | 0.35% | 76 |
|
|
2019
Q4 | $909K | Buy |
+14,171
| New | +$909K | 0.36% | 76 |
|